NewLink Genetics (NLNK) Tops Q1 EPS by 88c

Go back to NewLink Genetics (NLNK) Tops Q1 EPS by 88c

NewLink Genetics Reports First Quarter 2016 Financial Results

April 29, 2016 8:00 AM EDT

IMPRESS Phase 3 Top-line Results Now Expected in Second Quarter of 2016Pancreatic and Melanoma IDO Pathway Inhibitor Trial Updates at ASCO

-Management to Host Conference Call Today at 8:30 a.m. ET

AMES, Iowa and AUSTIN, Texas, April 29, 2016 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (NASDAQ: NLNK), a biopharmaceutical company at the... More